Loading…
Psyence Biomedical Ltd. is projected to rise to $4.21 by 2027, a +42% move from its current price of $2.97. PBM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.84 | $2.97 | $3.11 | +0.06% |
| Jul 14 | $2.79 | $2.97 | $3.17 | +0.11% |
| Jul 15 | $2.75 | $2.97 | $3.22 | +0.17% |
| Jul 16 | $2.71 | $2.98 | $3.26 | +0.22% |
| Jul 17 | $2.69 | $2.98 | $3.30 | +0.28% |
| Jul 18 | $2.66 | $2.98 | $3.34 | +0.33% |
| Jul 19 | $2.64 | $2.98 | $3.37 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.64 | $2.98 | $3.37 | +0.39% |
| Week 2 | $2.52 | $2.99 | $3.56 | +0.77% |
| Week 3 | $2.43 | $3.00 | $3.71 | +1.16% |
| Week 4 | $2.36 | $3.02 | $3.85 | +1.56% |
| Week 5 | $2.31 | $3.03 | $3.98 | +1.95% |
| Week 6 | $2.25 | $3.04 | $4.10 | +2.34% |
| Week 7 | $2.21 | $3.05 | $4.21 | +2.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Psyence Biomedical Ltd. is a healthcare company focused on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder in the context of palliative care.
Psyence Biomedical operates as a subsidiary of Psyence Group Inc. and is based in Toronto, Canada, with a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer.
PBM is the stock ticker for Psyence Biomedical Ltd. The current price is $2.91 with a listed market cap of $6.67M, and the company carries a rank of 5251. The near-term technical backdrop is bearish, with the RSI at 30.
A major floor 43.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
The nearest ceiling, 47.1% above — a clean break opens room to run.
A major ceiling 280.5% above — clearing it would confirm fresh momentum.
Key PBM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PBM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.99 | Sell | $2.98 | Sell |
| MA 10 | $3.02 | Sell | $3.01 | Sell |
| MA 20 | $3.06 | Sell | $3.17 | Sell |
| MA 50 | $4.06 | Sell | $4.13 | Sell |
| MA 100 | $3.81 | Sell | $14.80 | Sell |
| MA 200 | $37.49 | Sell | $711.76 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.56 | Neutral |
| Stoch RSI (14) | 83.25 | Sell |
| CCI (20) | -46.54 | Neutral |
| Williams %R (14) | -35.00 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 2.06 | Buy |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 65.00 | Neutral |
| TRIX (15) | -1.38 | Sell |
| Awesome (5,34) | -0.42 | Sell |
| Ultimate (7,14,28) | 39.93 | Neutral |
| Momentum (10) | 0.26 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 2.93 | Buy |
| ADX (14) | 23.94 | Sell |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is bearish, with RSI(14) at 30. The stock is below key moving averages, with SMA50 at $4.99 and SMA200 at $45.97. Near-term support is at $2.91 and resistance at $5.57.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.23 | $2.97 | $4.85 | 0% | Neutral | |
| $3.14 | $4.21 | $6.08 | +42% | Bullish | |
| $3.23 | $4.56 | $6.98 | +54% | Bullish | |
| $2.82 | $4.16 | $6.65 | +40% | Bullish | |
| $2.59 | $3.97 | $6.57 | +34% | Bullish | |
| $2.48 | $3.94 | $6.73 | +33% | Bullish | |
| $2.35 | $3.87 | $6.80 | +30% | Bullish | |
| $2.95 | $5.01 | $9.03 | +69% | Bullish | |
| $3.21 | $5.63 | $10.38 | +90% | Bullish | |
| $3.09 | $5.58 | $10.51 | +88% | Bullish | |
| $3.34 | $6.97 | $14.32 | +135% | Bullish | |
| $4.43 | $9.84 | $22.63 | +231% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.23 | $2.97 | $3.61 | +0.00% |
| August 2026 | $2.61 | $3.14 | $3.92 | +5.75% |
| September 2026 | $2.57 | $3.12 | $3.97 | -0.56% |
| October 2026 | $2.50 | $3.08 | $3.98 | -1.37% |
| November 2026 | $2.71 | $3.37 | $4.40 | +9.38% |
| December 2026 | $2.93 | $3.67 | $4.85 | +8.98% |
Click any year to see its month-by-month PBM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PBM could reach as high as $4.85, with a base case around $2.97 and support toward $2.23 — roughly 0% from $2.97. Price action looks broadly range-bound.
Expect PBM to range from $3.14 to $6.08 through 2027. The $4.21 average target implies a +42% move from current prices. That is up +42% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The PBM price prediction for 2028 points to an average of $4.56 (low $3.23, high $6.98) — a potential gain of +54% on today's $2.97. Momentum favours further upside here.
In 2029, PBM is projected to trade between $2.82 and $6.65, averaging $4.16 — a potential gain of +40% from today's $2.97. That is -9% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Psyence Biomedical Ltd.'s 2030 outlook centres on $3.97, within a $2.59 to $6.57 range. That is -5% versus the projected 2029 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2031, PBM could reach as high as $6.73, with a base case around $3.94 and support toward $2.48 — roughly +33% from $2.97. Buyers look set to stay in control over this stretch.
Expect PBM to range from $2.35 to $6.80 through 2032. The $3.87 average target implies a +30% move from current prices. That is -2% versus the projected 2031 average. Momentum favours further upside here.
The PBM price prediction for 2033 points to an average of $5.01 (low $2.95, high $9.03) — a potential gain of +69% on today's $2.97. Buyers look set to stay in control over this stretch.
In 2034, PBM is projected to trade between $3.21 and $10.38, averaging $5.63 — a potential gain of +90% from today's $2.97. That is up +12% on the projected 2033 average. Momentum favours further upside here.
Psyence Biomedical Ltd.'s 2035 outlook centres on $5.58, within a $3.09 to $10.51 range. That is -1% versus the projected 2034 average. That marks a +88% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, PBM could reach as high as $14.32, with a base case around $6.97 and support toward $3.34 — roughly +135% from $2.97. Momentum favours further upside here.
Expect PBM to range from $4.43 to $22.63 through 2050. The $9.84 average target implies a +231% move from current prices. That is up +41% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PBM today (≈ 336.700337 PBM) could be worth
$3,312.67
+$2,312.67 (+231%) by 2050 · US Dollar
Based on the average projected PBM price of $9.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PBMwould be worth at today's price.
$1,000 invested in PBM on Jul 10, 2025 (≈ 5.16129 PBM) would be worth
$15.33
-$984.67 (-98.5%) today · 0.02× · US Dollar
Based on a PBM entry price of $193.75 vs. today's $2.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.04 | $976.97 | -2.3% |
| 1 month ago | $3.28 | $905.49 | -9.5% |
| 3 months ago | $2.67 | $1,112.36 | +11.2% |
| 6 months ago | $31.05 | $95.64 | -90.4% |
| 1 year ago | $193.75 | $15.33 | -98.5% |
| All time (4.6y) ago | $232,031.25 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PBM forecast.
Our base-case forecast reaches $5.90 around 2040.
Implied market cap at $5.90: $22.5M
Forecasts show a mixed but increasingly bullish longer-term path. For 2026, the avg is $2.91 (min $2.23, max $5.19) with ROI 0 and neutral sentiment. By 2030, the avg rises to $4.02 with ROI 38% and bullish sentiment.
In 2040, the avg is $7.60 with ROI 161.2% and bullish sentiment, and by 2050 the avg reaches $9.85 with ROI 238.5% and bullish sentiment. These are estimates and not guarantees, reflecting potential upside over time within the provided ranges.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $4.02 with a 38% ROI and bullish sentiment.
The forecast path shows bullish sentiment in 2027 and beyond with rising averages and ROI, but 2026 is neutral and the current technical setup is bearish. These are estimates, not guarantees.
Yes. The forecast in 2033 lists a max of $10.18, indicating a possible move above $10 in that year.
PBM trades at $2.91 and has a market cap of $6.67M.
In 2026, the min is $2.23, the avg is $2.91, the max is $5.19, with ROI 0 and neutral sentiment.
Psyence Biomedical Ltd. Community Discussion
0Share your Psyence Biomedical Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.